Profile
ADILW CLBAX MER-PK FFICX CICAX NEE-PN
Company Name Adial Pharmaceuticals, Inc. WT EXP 073123 American Funds American Balanced 529A Merrill Lynch Capital Trust I GTD CAP 6.45% American Funds Invmt Co of Amer F3 American Funds Invmt Co of Amer 529A NextEra Energy, Inc. Series N J
Sector - - - - - -
Industry - - - - - -
Market Cap - $241.63B $201.90B $159.92B $158.97B $147.24B
Employees 0.00K 0.00K 0.00K 0.00K 0.00K 0.00K
CEO - - - - - -
Ratings
ADILW CLBAX MER-PK FFICX CICAX NEE-PN
Quant Rating Score 2 3 2
Quant Rating Sell Neutral Sell
Trading
ADILW CLBAX MER-PK FFICX CICAX NEE-PN
Last Close $0.0009 $35.25 $25.78 $59.39 $59.18 $23.83
High 52 - $37.11 $26.61 $64.42 $64.19 $25.5
Low 52 - $33.05 $25.15 $55.01 $53.72 $22.95
Price vs. 52 Week High 0 % -5.01 % -3.12 % -7.81 % -7.8 % -6.55 %
Price vs. 52 Week Low 0 % 6.66 % 2.5 % 7.96 % 10.16 % 3.83 %
Total Return
ADILW CLBAX MER-PK FFICX CICAX NEE-PN
1 Month Return 0 % -0.03 % -0.15 % -0.35 % -0.37 % -0.5 %
3 Month Return 0 % -3 % -1.15 % -4.16 % -4.18 % -3.83 %
6 Month Return 0 % -1.07 % -0.35 % 0.54 % 0.53 % -5.85 %
9 Month Return 0 % 3.59 % 1.54 % 0 % 4.93 % -2.89 %
YTD Return 0 % 2.89 % 0.39 % 3.04 % 2.99 % 2.72 %
1 Year Return 0 % 0 % 0.62 % 0 % 0 % -5.66 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
ADILW CLBAX MER-PK FFICX CICAX NEE-PN
Dividend Yield Percentage (TTM) - 1.99 % - 1.33 % 0.99 % 2.88 %
Dividend Paid and Capex Coverage Ration (TTM) - - -9.1 % - - 1.04 %
Dividend Per Share (TTM) - 0.71 % - 0.79 % 0.6 % 2.06 %
Payout Ratio (TTM) - - 26.64 % - - 60.98 %
Growth
ADILW CLBAX MER-PK FFICX CICAX NEE-PN
Asset Growth -17.38 % 4.22 % 11.67 %
Gross Profit Growth 99.07 % - 77.3 %
Revenue Growth - - 34.16 %
Revenue 3 Year - - 51.04 %
Revenue 5 Year - - 57.02 %
Revenue 10 Year - - 56.48 %
EBIT Growth 48.28 % - 150.85 %
Net Income Growth 45 % - 125.2 %
Net Income 3 Yeari Growth Per Share 77.43 % - 142.13 %
Net Income 5 Yeari Growth Per Share 91.95 % - 2.88 %
Net Income 10 Yeari Growth Per Share -14.98 % - 222.76 %
Operating Income Growth 48.28 % - 150.85 %
Operating Cash Flow Growth (CFG) 39.15 % - 36.78 %
Operating 3 Year CFG 68.78 % - 36.88 %
Operating 5 Year CFG 63.58 % - 60.13 %
Operating 10 Year CFG -96.53 % - 86.75 %
EPS Growth 54.59 % - 118.79 %
EPS Diluted Growth 54.59 % - 119.51 %
Book Value Per Share -6.96 % -100 % 16.24 %
Share Holder 3 Year Equity Growth Per Share -64.14 % - 25.7 %
Share Holder 5 Year Equity Growth Per Share -87.71 % - 29.88 %
Share Holder 10 Year Equity Growth Per Share 236.21 % - 121.67 %
Dividend Per Share Growth - - 9.85 %
Dividend 3 Year Growth Per Share - - 33.31 %
Dividend 5 Year Growth Per Share - - 68.17 %
Dividend 10 Year Growth Per Share - - 183.97 %
Debt Growth -100 % 11.47 % 12.69 %
Free Cash Flow Growth 100 % - 218.45 %
Updated On 31 Dec 2023 31 Dec 2023 31 Dec 2023
Profitability
ADILW CLBAX MER-PK FFICX CICAX NEE-PN
Gross Profit Margin TTM 98.69 % -11.67 % 54.45 %
Return on Assets TTM -194.36 % 0.85 % 3.65 %
Return on Equity TTM -256.25 % 9.62 % 14.04 %
Return on Capital Employed TTM -138.14 % -0.3 % 4.55 %
Net Income Per EBT TTM 100.12 % 93.48 % 115.06 %
EBT Per Ebit TTM 160.33 % -310.42 % 80.52 %
EBIT Per Revenue TTM -25204.88 % -21.35 % 30.23 %
Cash Flow To Debt Ratio TTM - -19.9 % 16.11 %
Receivables Turnover TTM - - 5.2
Payables Turnover TTM - - 1.62
Inventory Turnover TTM - - 5.1
Fixed Asset Turnover TTM - 379.18 % 17.86 %
Asset Turnover TTM 0.48 % 1.37 % 13.04 %
Operating Cash Flow Per Share TTM -1.15 -8.76 6.45
Free Cash Flow Per Share TTM -1.15 -8.76 2.31
Cash Per Share TTM 89.18 % 422.08 % 72.29 %
Operating Cash Flow Sales Ratio TTM -20749.98 % -150.12 % 53.47 %
Free Cash Flow Operating Cash Flow Ratio TTM 100 % 100 % 35.79 %
Cash Flow Coverage Ratios TTM - -19.9 % 16.11 %
Price To Free Cash Flows Ratio TTM -0.76 -2.95 31.02
Price To Operating Cash Flows Ratio TTM -0.69 -2.95 11.1
Price Cash Flow Ratio TTM -0.69 -2.95 11.1
Income Statement (TTM)
ADILW CLBAX MER-PK FFICX CICAX NEE-PN
Revenue $0B $94.95B $17.02B
Gross Profit $-0B $58.5B $17.02B
Gross Profit Ratio 0% 61.61% 100%
EBITDA $-0.01B $32.95B $7.16B
Net Income $-0.01B $27.53B $4.54B
EPS Diluted -5.44 3.37 2.21
Balance Sheet (MRQ)
ADILW CLBAX MER-PK FFICX CICAX NEE-PN
Long Term Debt $0B $302.2B $0B
Total Liabilities $0B $2888.51B $129.28B
Total Equity $0B $291.65B $50.5B
Total Investments $0B $8.35B $15.92B
Total Debt $0B $342.76B $9.95B
Total Assets $0B $3180.15B $190.14B
Cash Flow Statement (TTM)
ADILW CLBAX MER-PK FFICX CICAX NEE-PN
Net Income $-0.01B $27.53B $5.7B
Inventory $0B $0B $0B
Dividends Paid $0B $0B $-4.24B
Operating Cash Flow $-0.01B $-6.33B $13.26B
Capital Expenditure $0.01B $0B $-8.51B
Related Stocks
Ticker Name Price
AAACX Alpha Alternative Assets Fund 6.42
AAC-WT Ares Acquisition Corporation Re 0.63
AACQU Artius Acquisition Inc. 11.05
AADEX American Beacon Large Cap Value R5 27.25
AAIDX Axonic Alternative Income Fund 20.37
AAIN Arlington Asset Investment Corp 23.5
AAQC-WT 0.0057
AARTX Stone Ridge Trust VIII 10.62
ABRTX ABR DYNAMIC BLEND EQUITY & VOLATILITY FUND - INVESTOR SHARES 11.19
ACCNX American Century Core Plus Fd Investor Cl 9.16
ACHR-WT 3.03
ACRO-WT 0.0105
ADEX-WT Adit EdTech Acquisition Corp. R 0.084
ADRA-WT Adara Acquisition Corp. 0.0488
AEMGX Acadian Emerging Markets Portfolio Investor Class 23.8
AEVA-WT Aeva Technologies, Inc. Redeema 0.0693
AFDVX Applied Finance Explorer fund Investor Class 21.58
AFJKR Aimei Health Technology Co., Ltd Right 0.2323
AFTR-WT 0.0041
AGAC-WT African Gold Acquisition Corpor 0.0095
Unlock